Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary

March 21, 2024

New York Stock Exchange US Financials Insurance earnings

Earnings Call Speaker Segments

Garrett Edson

executive
#1

Hello, everyone, and thanks for joining and holding on. For the press release, investor materials, and SEC filings covering risks that could impact the business, Abacus Life directs those on this call to the investor page at www.abacuslife.com/investors. Listeners are pointed by Abacus Life specifically to the presentation filed today on Form 8-K with the Securities and Exchange Commission, and we want to remind everyone that certain remarks made today might include forward-looking statements, and because of that, they will carry risks and uncertainties that, should they occur, could significantly impact results. Please see the Forward-Looking Statements section in the earnings press release for the fourth quarter of 2023, which is incorporated here by reference. We note that forward-looking statements, written or oral, encompass, without limitation, Abacus Life's expectations or forecasts regarding financial and business information, performance and conditions, along with its competitive and industry outlook. Risks, uncertainties, and assumptions apply to forward-looking statements, including the risk factors described in Item 1A of our latest 10-K, which, if realized, could significantly impact results, and no guarantee of performance is provided by such forward-looking statements, and Abacus Life offers no assurances of that kind. No duty exists for Abacus Life, and it explicitly rejects any duty, to update, change, or otherwise amend any forward-looking statements, whether from new information, future events, or anything else, unless the law requires it. Furthermore, historical data concerning operating results and other performance indicators relevant to Abacus Life may not be indicative of what will be achieved in later periods. I'll now hand the call over to Jay Jackson, Abacus Life's Chief Executive Officer.

Jay Jackson

executive
#2

I want to thank everybody who joined the call today for taking an interest in Abacus, and I'd like to welcome you to our earnings call for the fourth quarter of 2023. Joining me is Bill McCauley, our Chief Financial Officer, and once we've finished our prepared comments, we'll turn things over to you for your questions. We closed out 2023 with yet one more quarter of solid results and profitable growth, which put a bow on a record-setting year for Abacus, surpassing the record we had set in 2022. Looking ahead to 2024, our differentiated business model leaves us well positioned to build further on our momentum, and thanks to the recent introductions of ABL Wealth and ABL Tech, which I'll get to shortly, we're making progress when it comes to capitalizing on our technological advantages, growing our total addressable market, and turning into a full-fledged alternative asset manager. In the fourth quarter of 2023, our total revenues rose 25% compared with the same period a year earlier, reaching $23.6 million, and we turned in strong earnings, posting Adjusted EBITDA of $11 million along with adjusted net income of $5.9 million. Across all of 2023, total revenues came to $79.6 million, which represents 14% growth over the previous year, and Adjusted EBITDA climbed 13% year-over-year to $39.3 million, with adjusted net income of $29.4 million. During 2023, we raised our new policy originations by 30%, reaching 633 for the year, and we paid out more than $200 million to policyholders. A large share of that growth came from our carrier partnerships and our expanding reinsurer relationships. On top of that, in the fourth quarter, our board of directors gave the go-ahead for a stock repurchase program worth $15 million. As of March 19th, 2024, 8.1 million of stock had been bought back at a weighted average price of $11.20 per share. Right now, $6.9 million of availability is left under that program. In addition, warrant holders have begun exercising their warrants at the strike price of $11.50, and so far we've brought in $3.5 million in proceeds. Bill will join us in a bit to go through the fourth quarter and full year 2023 financial performance in greater detail. Our demonstrated business model, knowledgeable team, rich data, and cutting-edge technology leave us positioned to carry out our various strategic initiatives, seize the many exciting opportunities ahead, and in the end build long-term value for our shareholders. Over the last several months, we've taken significant steps to launch and grow our newest initiatives, ABL Wealth and ABL Tech, and I'd like to take a couple of minutes to explain how we anticipate both will strengthen our business model in the years to come. To begin, as you might remember, in November we introduced ABL Wealth in order to provide clients with tailored, lifespan-based financial solutions, working alongside one of the nation's top wealth management platforms for independent wealth management firms. The thinking behind ABL Wealth comes from our conviction that treating lifespan and longevity as a central tool when crafting customized personal wealth solutions will transform the retail financial services industry at its core. Through ABL Wealth, we sit at the crossroads of life insurance, lifespan and longevity, and wealth management. During 2024, we began making the most of the leads coming from our Abacus marketing efforts, among them the thousands of in-house inquiries, and we're starting to craft bespoke asset management solutions for our clientele; we'll keep partnering with RIAs and broker-dealers so our product range grows and our interests stay aligned as we move further forward. Also, ABL Tech was introduced last month to the pension fund and financial services sectors. Across our 20-year history, we've gathered a treasure trove of longevity data and built proprietary technology and analytics that guide how we make investment decisions when acquiring policies. ABL Tech now aims to harness that rich store of data and technology, together with AI and advanced algorithms, to build a set of tech-driven offerings for the pension fund and financial services sectors. The solutions we provide include mortality verification and participant verification. Through AI and advanced algorithms, we verify mortality and participant locations more efficiently, which helps pension funds safeguard assets and stop fraud. We're also drawing on AI and real-time lifespan data to deliver strategic wealth distribution analysis and lifespan valuation, something essential for insurers and wealth managers seeking better forecasts of the asset value of investor wealth across a lifespan. We've also built the Abacus Marketplace, a multi-platform digital portal that boosts life settlement, sector communication, and transparency, and that streamlines end-to-end access and processes for clients, advisors, and investors; we anticipate top-line contributions from both ABL Wealth and ABL Tech in 2024. Beside these new initiatives, our core origination and asset management vertical, known also as ABL Longevity Funds, keeps humming along nicely, since we just finished our 20th consecutive year of GAAP profitability while still producing strong margins. What's more, our new mutual fund, the ABL Longevity Growth and Income Fund, is still on track to launch later this year, and its potential has us very excited. Looking forward, we stay confident in our business, in the opportunities across our total addressable core market, and in the remarkable stability of our asset class. A reminder: our industry today has only roughly 2% market penetration of an opportunity worth $233 billion+, with a substantial financial incentive for individuals who sell their policies. Given fresh investor interest from institutions as well as life insurance companies, that's a sizable gap we think we can narrow in time. We'll keep teaching policyholders about what their policies are worth via our network of more than 30,000 financial professionals and via television and digital campaigns for our expanding direct-to-consumer channel. And with our broader verticals plus deep data and technology advantages, we're well along the path to becoming a true, vertically integrated alternative asset manager with numerous revenue and profit streams. We stay enthusiastic about our historical, current, and future trends, and about our potential for anticipated origination growth and lasting long-term profitability. Having said that, I'll pass things along now to Bill McCauley, our CFO, so he can walk through the details of what we saw in Q4 on the results and financials side.

William McCauley

executive
#3

Thank you, Jay, and good morning to all of you. As Jay pointed out, we turned in yet another robust quarter, with growth on the top line and profitability throughout our operations. Our extremely efficient origination platform remains the primary force behind how the business performs. During Q4 of 2023, capital deployed for originations rose roughly 92%, reaching $68.3 million, up from $35.5 million during the same period a year earlier, a result of larger face value policy acquisitions, and we simultaneously kept up 79% growth in policy originations, hitting 208 versus 116 in the comparable period last year. Total revenue for the fourth quarter of 2023 climbed about 25%, landing at $23.6 million, versus $18.8 million a year earlier. That gain came mainly from robust results in every segment. Across the entirety of 2023, revenue rose 14% to $79.6 million, up from $69.7 million the previous year. This improvement was driven chiefly by more policy acquisitions along with realized trade revenue. At December 31, 2023, Abacus held 296 policies; 287 of those fall under the fair value method, while 9 use the investment method, meaning cost plus premiums paid. A quick reminder: for every policy bought after June 30, 2023, the company has chosen to use the fair value method from here on. For policies bought prior to June 30, 2023, the company selected either the fair value approach or the investment method. Our portfolio servicing segment brought in $0.2 million of revenue during Q4 2023, versus $0.1 million a year earlier. Now for expenses: total operating expenses, leaving out unrealized gains and losses on investments and change in fair value of debt, for Q4 2023 came to roughly $18.9 million, compared with $4.4 million in the same period last year. Worth noting is that Q4 2023 total operating expenses contained $6.2 million in non-cash stock compensation expense plus $2.5 million in public company-related expenses, and neither of those existed a year earlier. We also raised sales and marketing expenses by about $2 million versus the prior year period, which helped speed up our growth trajectory during 2023. Normally the company sees the payoff from marketing spend within 90 to 120 days... Just like Q4 2023, total operating expenses during the first half of 2024 will run higher than the prior year period because of non-cash equity compensation expenses, plus continuing public company expenses that were absent in the first half of 2023. We'll start lapping non-cash equity compensation and public company expenses in Q3 of 2024. Adjusted EBITDA for the quarter came in at $11 million, fairly in line with $11.1 million a year earlier. Adjusted EBITDA margin for the quarter stood at 47%, versus 52% in the same period last year. For all of 2023, adjusted EBITDA rose 13% to $39.3 million, compared with $34.8 million the year before. For 2023, our adjusted EBITDA margin came in at 49%, versus 50% during the previous year. Looking at the quarter, GAAP net loss attributable to stockholders stood at $6.2 million, while in the same period a year earlier we had GAAP net income attributable to stockholders of $10 million. When we adjust for non-cash stock compensation, amortization, and change in fair value of warrant liability, net income for the fourth quarter of 2023 came to $5.9 million, versus $9.5 million a year earlier; for the full year 2023, adjusted net income reached $29.4 million, compared with $32.3 million the year before. Let's move on to our balance sheet metrics. On an annualized basis, for the three-month period ended December 31, 2023, return on equity was 18% and return on invested capital was 17%, which reflects how profitable our business model is. At December 31, 2023, the company held cash and cash equivalents of $25.6 million, balance sheet policy assets of $124 million, and outstanding long-term debt at fair value of $89.1 million. In the fourth quarter, we were glad to wrap up our public bond offering successfully, directing the proceeds toward refinancing prior debt and bringing down the interest rate on our prior debt by roughly 275 basis points; all told, we're happy with the strong results this quarter and we keep delivering double-digit growth on our top line, along with solid profitability on an adjusted basis. We're still quite enthusiastic about the growth opportunities that lie ahead and are well-positioned to execute on our long-term plans. I'll now hand it back to our CEO, Jay Jackson, for our closing comments.

Jay Jackson

executive
#4

Appreciate that, Bill. In closing, our view is that Abacus Life sits in a strong spot to seize a sizable market opportunity in a sector that's changing quickly right now. Not many other business models can point to 20 years of steady net income, a target market that's growing and exceeds $200 billion, plus fresh avenues for growth like ABL Wealth and ABL Tech. It's a point of pride for us to be a growth company that has delivered dependable long-term profitability. Many thanks to each of you for being with us today, and we're grateful for your interest in Abacus Life. At this point, we're ready to take any questions.

Andrew Kligerman

analyst
#5

Good afternoon, Jay and Bill. My question concerns revenue and origination capital; revenue appeared to rise 14% compared with the same period a year earlier. You mentioned greater policy acquisition and realized trade revenue, while origination capital climbed 46%, driven by policy originations with bigger face and bigger face value as well as count. The figures look excellent. Should we anticipate this type of pattern for both items as we move into 2024? What is your outlook for 2024 regarding revenue and origination capital, each respectively?

Jay Jackson

executive
#6

Thanks, Andrew. It's great to hear your voice too; and yes, the response is affirmative. We are enthusiastic about what 2024 may bring. This pattern actually began several years back, and we have observed growth in the size of the policies we acquire, and by now you have witnessed, almost compared with a year earlier, greater deployment of capital. Yet you have also witnessed a notable rise in how many policies we acquire. I believe this traces back to, first, our marketing capability. We have participated in this market for a long time; we possess truly well-established relationships with financial professionals throughout the country. We have likewise observed a very favorable effect from our advertising aimed at expanding our direct-to-consumer channel and division, where our count of new policy originations, I think, also signals this, since we were up more than 30% versus the equivalent period a year prior. So, it truly comes from two sources, correct? We are buying additional contracts that furthermore carry greater face value, which pushes up how much capital gets deployed. And then, considering a sort of main factor, that figure for capital deployed, it would subsequently feed into your growth compared with a year earlier at both the top line and bottom line of your Adjusted EBITDA. And actually, I would even point out, if you examine the equivalent period a year prior or the year-over-year change in Q4, not only 2023, but if you examine Q4, you observed the Adjusted EBITDA figure, even though it appeared unchanged from one year to the next. Yet accounting for the fact that we raised our marketing by $2 million during the fourth quarter, we incurred public company expenses, an additional $800,000 beyond the equivalent period a year earlier. We are discussing $2.8 million in extra EBITDA that would effectively have been present at 25%; so that would have aligned with the top line, correct? You would have had a fourth quarter-

Andrew Kligerman

analyst
#7

Understood.

Jay Jackson

executive
#8

We saw a 25% increase at the top line and 25% in revenue, yet we redirected those funds straight back into the company so we could properly position ourselves for 2024.

Andrew Kligerman

analyst
#9

Understood. So it seems that this pattern carries on through 2024.

Jay Jackson

executive
#10

That's right. And, you know, I believe this matters to us, and it matters to everybody to grasp that we are going to keep putting money back into our company to fuel expansion. And I think that is among the more persuasive elements of what we have to tell.

Andrew Kligerman

analyst
#11

Possibly regarding those overall operating costs, if I exclude the non-cash compensation,

Jay Jackson

executive
#12

Yes.

Andrew Kligerman

analyst
#13

My understanding is that the figure came to roughly $14 million for the quarter — is that correct?

Jay Jackson

executive
#14

That's right.

Andrew Kligerman

analyst
#15

Is that a run rate we ought to use, or should we gradually raise it, given what you said about heavy reinvestment?

Jay Jackson

executive
#16

My preference has always been to promise less and deliver more. I don't want to overextend it. That said, we are working toward that larger net and EBITDA figure. As with anything, putting money into reaching that figure brings bigger costs along the way, yet the eventual outcome of doing so is extremely favorable, and that is exactly what you are observing.

Andrew Kligerman

analyst
#17

Understood. And perhaps, if I may squeeze in a final question. Regarding ABL Tech — I'm simply sort of wondering, what would the revenue be—

Jay Jackson

executive
#18

Yes.

Andrew Kligerman

analyst
#19

What kind of potential does that investment hold?

Jay Jackson

executive
#20

In what way does that— Jay Jackson: Of course.

Andrew Kligerman

analyst
#21

How might this unfold? Perhaps during this current year, and then looking ahead by 3 or 4 years?

Jay Jackson

executive
#22

Absolutely. One way to frame ABL Tech and our efforts in that space is that it encompasses far more than a single business line. We handle valuation and servicing there; we perform substantial lifespan and longevity work that supports other segments of our operations. Given that, you'll notice growth in areas such as ABL Wealth, where we apply that technology and the lifespan capabilities for things like, you know, financial planning. Leveraging lifespan, I believe, is quite compelling and would also assist in propelling upcoming investment products we create and tailor for that purpose. Yet another aspect that feels truly concrete is that we've conducted mortality verification for our own accounts and the funds we've overseen for more than 10 years. And extending that capability to additional clients, we find genuinely thrilling; we're already bringing on clients, major institutions and insurance firms that employ it for mortality verification. And when you consider sectors such as the pension fund industry, when you consider the magnitude, extent, and reach of that market, the states, we're in discussions with states regarding, you know, improved ways to handle certain pension liabilities, where they could be overpaying or possibly even confronting potential fraud. So that market, what's intriguing is that it's enormous. So what I don't want to do is claim, "Oh, hey, in the coming year we anticipate X," yet we do expect that segment of our operations generally to become a major component of our overall revenue moving forward. Expanding 3 and 5 years ahead, this would be a major component of our revenue and a driver of our revenue, and the margins for that business are outstanding. I believe over the next year, as we keep developing it, it'll be gradual. It'll be slower during the initial year, and then you'll witness 2, 3, 4, 5 years, this portion of the business truly accelerates.

Andrew Kligerman

analyst
#23

Understood. That's very clear. Many thanks.

Jay Jackson

executive
#24

Appreciate it, Andrew.

Wilma Burdis

analyst
#25

Hi there, good afternoon, all.

Jay Jackson

executive
#26

Is there anything new you can share regarding the mutual fund launch, and perhaps discuss— Jay Jackson: Of course.

Wilma Burdis

analyst
#27

- what's the size of that revenue chance?

Jay Jackson

executive
#28

Absolutely. Thanks, Wilma. An amended prospectus has been submitted by us — it's already on file. As far as I know, the most recent version can be found publicly online. That marked round four of comments from the SEC. We've trimmed those considerably, I'd say, and that opportunity has us quite enthusiastic. Right now we're awaiting word regarding what the upcoming set of comments might look like. Still, we're optimistic that we've managed to address the SEC's responses throughout this process, and our aim is to reach that point, you know, with a target around late April. I realize that's shifted by a few months compared to our original expectation, which was nearer to February. Given everything involved, though, you know, this is the first SEC product of this type. They've said as much, and they're putting in extra due diligence effort simply to confirm that, you know, our disclosures are appropriate. All in all, we believe it's going to be a product that, at least for our company, delivers a major effect, especially inside ABL Wealth; it'll be an interval fund carrying its own ticker, and basically open to the public, distributed via RIAs and other channels, through RIAs and broker-dealers, and so on. So there's already a substantial level of interest in this product, where funds have, you know, others have commented, "Wow, you know, we've looked at the filing. That would really interest us." Of course, we're unable to hold those discussions with them until our prospectus is clean, which once more, we hope arrives at some point within the coming 30 days. Even so, we feel the general interest and the boost to our revenue will be major as well, and that's going to be major during 2024 and clearly beyond; and so, you know, it'll touch multiple parts of our operations, and at this moment we're simply waiting patiently for further feedback from the SEC, though we anticipate that quite, quite soon.

Wilma Burdis

analyst
#29

All right, thanks. And then perhaps you could say a few words about the deployment pipeline — where things stand with your capital position, the capital you anticipate generating, and what you're able to deploy?

Jay Jackson

executive
#30

Sure. As I believe Bill pointed out, our capital deployment in the fourth quarter was a record. I think it came to $68 million.

William McCauley

executive
#31

Yeah.

Jay Jackson

executive
#32

On a year-over-year basis, that figure climbed by nearly 100%; 2023 also stood as a record year for us when it came to deploying capital — $218 million, if you recall. So what we can observe is that, given the money we're putting back into Abacus along with our operations on the marketing and distribution side, we anticipate carrying that same momentum forward with capital deployment. From where we sit, that brings us to the idea of bringing more capital onto the balance sheet eventually. Whether that arrives via an interval fund, a mutual fund product, or through some other route — perhaps a bond, which is what we did in January, and we felt quite proud of that one, incidentally; demand was strong enough that it was oversubscribed — or through different kinds of equity financing instruments, especially around the question of whether we might issue additional primary shares by way of a secondary offering. All of these possibilities sit at the front of our thinking, and we're collaborating closely on them. Because at this moment, when it comes to capital deployment, the constraint isn't the opportunities in front of us or the revenue those are generating. That matters a great deal, and we want to keep doing it, but the real issue is the deals we aren't doing. When you consider that, there are opportunities and contracts we aren't buying, and with more capital sitting on our balance sheet, we'd be in a position to seize those opportunities, and doing so would be accretive from day one. This is the sort of situation where having more capital would produce a favorable effect on our balance sheet. So a range of ideas and options are underway at present, allowing us to keep tackling this and grow the capital held on our balance sheet.

Wilma Burdis

analyst
#33

All right, thanks. And then, I suppose just one final item — if you wouldn't mind saying a bit regarding what's in the pipeline when it comes to further carrier partnerships, without, you know, without mentioning any specific names, but simply,

Jay Jackson

executive
#34

Yes

Wilma Burdis

analyst
#35

Let's discuss that area.

Jay Jackson

executive
#36

Of course. That's still expanding. I believe we currently partner with one major carrier. Several others are engaged with us in serious discussions, and that interest will keep building. When we go to conferences and talk with them face-to-face, we keep discovering that this need is genuine, and it will remain so. From the carrier's side, the difficulty is that they've observed our sector across the years. Perhaps their past encounters or impressions of our sector haven't been great, and we've made it our mission to alter that; being listed on the public market—since we're the sole company trading publicly in our space—I believe hands us a big edge during those talks, because when we deal with governance committees at carriers, one of the main items they seek is transparency, regulatory. Are we capable of handling this transaction as transparently as we can, and likewise, being governed by the same regulatory standards that a lot of these carriers face publicly, rather than only at the state level. So, those discussions are progressing extremely well. We're pushing those discussions forward at a very fast pace. I'd say across the past 6 months, things have accelerated dramatically. And we expect that in the coming 12 months, it will accelerate even more, since more opportunities have appeared. Also, what matters regarding those carriers is that this deal benefits both sides right down to the policyholder, because, as we all know, policyholders usually experience quite high lapse rates, and this lets them handle their policy as equity, and afterward that policy might lapse and they can direct that capital toward other purposes. For the carrier, this creates a strongly favorable effect on their legacy liabilities, their balance sheet. So once you begin to weigh all these benefits, carriers are starting to examine this and conclude, "This ought to be among the many actions they take in handling their legacy liabilities." Yet it shifted from, "This is something we'll consider," to it now being a top 2 or 3 item.

Wilma Burdis

analyst
#37

Great. Thank you very much.

Jay Jackson

executive
#38

Thank you, Wilma.

David Bastian

analyst
#39

Hi Jay. Hi Bill. I appreciate you answering my question. Just a fast one regarding policy originations. I believe you both mentioned earlier that the bulk of what you're currently engaged in is essentially trading policies — purchasing them and reselling them inside a fairly brief window. Should we keep anticipating that same rhythm throughout 2024? Or do you foresee any shift toward keeping more of them on your balance sheet over a longer horizon?

Jay Jackson

executive
#40

Hi David. Thanks. Wonderful to hear from you, and that's a really solid question. We stay flexible at all times, since the greatest chance to optimize returns exists in every contract; and based on how things appear right now, we usually trade a greater number of contracts inside our active management portfolio rather than retain them on our balance sheet across time. As the balance sheet expands further and further, it seems only natural to expect and to move toward keeping a portion of these contracts for an extended duration on our balance sheet. You can follow that via realized and unrealized gains on those contracts. That said, an active management component will always exist in our operations, given how strongly these contracts are in demand. Being capable of capturing that revenue and that profit now, rather than allowing those contracts to mature across multiple years, strikes us as an extremely wise business model; yet I'd also mention that, as our institutional relationships grow — be it with insurance carriers or be it with other private institutional asset managers — demand for the asset runs quite high. And I believe it matters that we constantly weigh and optimize our capital and our capital flows in the smartest possible manner. So as we move into 2024, and we begin placing additional capital onto our balance sheet, that could shift some of the positioning regarding how much we retain versus how much we choose to trade and realize at that moment; but simply remember, we're keeping outstanding assets on our balance sheet that deliver, historically speaking, excellent returns with, basically, an uncorrelated underlying asset that trades and behaves far more like a mortality-driven zero. So, addressing your question directly, I believe we'll stay flexible right now and act opportunistically regarding the finest approach to manage and generate revenue for the company's balance sheet.

David Bastian

analyst
#41

Understood. Appreciate it; that is definitely a good approach for handling the cash flow issue that has troubled a number of the people who held your role before.

Jay Jackson

executive
#42

I agree.

David Bastian

analyst
#43

For my second question — it seems like, on the ABL Wealth and ABL Tech side, a fairly sizable amount of expense has gone into getting those operations up and running. Do you have a ballpark sense, say for the fourth quarter, of how much of that spending is being directed toward these new revenue streams that we expect to begin showing up over the coming couple of quarters?

Jay Jackson

executive
#44

Absolutely. The interesting piece there is that launching those lines did not carry the level of expense you might imagine, because remember, take ABL Tech first — we'd already been at this for years, correct? That meant the underlying infrastructure basically existed already. We simply built on top of it. So the costs in total weren't tied to starting something new, since it was already there. It came down to bringing in more labor, plus a bit of technology supporting that. So when we examine our costs on a relative basis, the fourth-quarter uptick had less to do with standing up ABL Wealth and ABL Tech, and stemmed more from origination expenses tied to writing additional contracts during the fourth quarter. To be specific, one of the biggest expense jumps we saw in the fourth quarter came from marketing and advertising, and that had nothing to do with ABL Wealth or ABL Tech. So from where we sit, we're introducing these added lines on top of the base we already possessed; the extra costs you see are tied more to labor than to infrastructure.

David Bastian

analyst
#45

Okay, so that definitely helps us on the incremental margin side as we head into 2024.

Jay Jackson

executive
#46

Yeah. Yeah.

David Bastian

analyst
#47

Understood. Thank you, everyone. I appreciate the time you've given us.

Jay Jackson

executive
#48

Any time. Thank you, David.

Matt Howlett

analyst
#49

Oh, hi there, Jay and Bill. I appreciate you answering my question.

Jay Jackson

executive
#50

Of course. Hello, Matt.

Matt Howlett

analyst
#51

Hi, just building on what was said about spending on sales and marketing — could you share where things stand with the direct-to-consumer channel? That channel delivers your best margins, after all. Jay, the advertisements and TV spots are great to watch.

Jay Jackson

executive
#52

Todd, bring us up to date; from the sound of it, that channel might make a real difference to the bottom line as you put money into— Jay Jackson: Yes

Matt Howlett

analyst
#53

and expand that channel.

Jay Jackson

executive
#54

Absolutely. The brief update on that front is that yes, this channel played a major role, not only during Q4 but throughout the entirety of 2023. That ad campaign got underway in January 2023, and it has. It's performed better than we had anticipated, and that's exactly why we made the substantial investment later in the year, during the fourth quarter of 2023. We observed close to a doubling in the count of originations coming through the direct-to-consumer channel. So from where we sit, as we're now looking ahead to 2024, and as Bill pointed out earlier on this call, Jim, there's usually a delay of 90 to 120 days between the moment your marketing and advertising dollars go out and the moment that marketing's effect shows up. And so the way we think about it and the way we examine this is that 2024 is set up really nicely, on the strength of that marketing spend from the fourth quarter of 2023. So even though our EBITDA took a somewhat larger expense hit, we believe it was justified as we head into 2024.

Matt Howlett

analyst
#55

Just to go over this one more time, when a policyholder comes straight to you, the deal they receive is every bit as favorable as what they'd get by using a broker. Basically, what you're doing is removing the intermediary. Is that more or less how to—

Jay Jackson

executive
#56

Correct.

Matt Howlett

analyst
#57

It does.

Jay Jackson

executive
#58

For our part, you don't require an auction to establish what a life insurance contract is worth. A calculator is what you need. It's just a straightforward net present value calculation. And given the consolidation that's happened in our industry... Most of the capital is deployed by only a handful of companies. As a result, things are much more efficient than they used to be. That means there's a significantly bigger chance for the policyholder simply to gain a far clearer picture of the true worth of their policy, without paying substantial intermediary expenses to get it; and-

Matt Howlett

analyst
#59

Correct.

Jay Jackson

executive
#60

... and thanks to that, we can bring in additional policies far more efficiently, and simultaneously the person holding that policy stands to gain, since they might end up with a bigger chunk of capital. So from our standpoint, this is very logical; and honestly, it lets us reach a considerably wider group of people.

Matt Howlett

analyst
#61

Certainly. Speaking of which, I notice policy acquisitions have risen 30%, yet folks get quite enthusiastic when considering how much Abacus might grow. So please explain to us what this TAM actually is, and what this market opportunity amounts to.

Jay Jackson

executive
#62

Yes

Matt Howlett

analyst
#63

... clearly, there's a great deal you're setting aside here. When it comes to your cost of capital—

Jay Jackson

executive
#64

Correct.

Matt Howlett

analyst
#65

... it declines and you expand, I mean, the growth simply appears as though it's simply, it might be enormous moving forward.

Jay Jackson

executive
#66

Yeah, That's precisely correct, and that is precisely the way we view the company, right? I mean, you examine the addressable market, there's still over 200, 200 million dollars annually that lapses past age 65, and, you know, our sector hardly touches that, right? And so at this point we're beginning to examine this and say... Or pardon me, 230 billion, not million, and we've hardly scratched the surface on that. As we now have, what I believe is truly fascinating, you have perhaps, you know, life insurance carriers that are thinking about buybacks. That contributes and in fact confirms. You know, they aren't a rival to me. To me, they confirm what we're doing.

Matt Howlett

analyst
#67

Right.

Jay Jackson

executive
#68

This gives those policyholders more knowledge, and they start thinking: "Wow, my policy ought to be viewed as equity rather than as debt." If a policy truly carries equity value, why would anyone simply abandon it, allow it to lapse, or halt premium payments? And when you consider that kind of education, and when you consider the advertising we do, education is the whole point; we offer a calculator. No one else provides a calculator; ours exists so that people become informed; they grasp that value resides in their policy, and that value is genuine. Given that, you can begin examining how we go about capturing or pursuing that $230+ billion destined to lapse beyond age 65; education, transparency, legitimacy, and validation all drive it. Once they observe that, hey, we're a public company, this is a real transaction, it gives those policyholders considerable reassurance as they weigh selling this transaction.

Matt Howlett

analyst
#69

For sure. That's completely logical, and honestly it's a model unlike any other. One more thing, Jay and Bill. Look, I have to give you credit for that repurchase program. You're among just a handful of businesses that came to the market via a SPAC and have actually been doing this; and at this point you're telling us a portion of the warrants are beginning to be exercised, which means cash is flowing your way-

Jay Jackson

executive
#70

Yeah

Matt Howlett

analyst
#71

...in a way that boosts earnings per share. It just — and take us through what's still left on the warrants that haven't been exercised.

Jay Jackson

executive
#72

You know, just discuss how that's going to be just, you're just in a — once again, not many companies that we've observed have listed through a SPAC- Jay Jackson: Correct

Matt Howlett

analyst
#73

...finding yourself in a spot so distinctive and enviable as the one you occupy.

Jay Jackson

executive
#74

Well, I appreciate that. Truly, I can't — off the top of my head, I don't know of many publicly traded firms, whether that came about through a SPAC-

Matt Howlett

analyst
#75

Right

Jay Jackson

executive
#76

... or simply entering the public markets during their initial year, which likewise executed a buyback. And, you know, we examined it since we viewed our shares as a holding and believed it was an asset priced below its worth. And why wouldn't we repurchase at those valuations given the profits and the basics that we possessed, you know, at that moment? And that reaction and story has been extremely favorably received by the public. And, you know, because of that, as the share price, you know, went above $11.50, which was the price for exercising warrants, warrant holders are seeing our chance to possess the common stock over the long haul, and they're changing those or exercising their warrants into common stock, which is, you know, essentially placing cash onto our balance sheet. So when you consider the $8.1 million that we've used in the buyback, we've gotten $3.5 million back through exercised warrants. Truly, that's lowered our expense of the buyback substantially. And I believe that, you know, it was an absolute, sort of victory for us, that we didn't intend for at the start; we were merely examining our company and believed our stock was priced below its worth. And, and then when you saw the warrants beginning to exercise, it's essentially transforming, people into long-term shareholders and believers in our stock. So, we, we couldn't feel more pride or joy regarding how that, process has functioned, in addition to that, generating a truly favorable story. Now, how many additional outstanding warrants exist? There's roughly a bit more than 17 million outstanding warrants. And we believe that, you know, as we keep delivering outcomes such as this, those warrant holders will, you know, keep seeing the chance to exercise and become common stockholders. So you know, any warrant holders present, we are as vigorously as we can, you know, conveying to them this story, and luckily, we're witnessing them become long-term stockholders due to it. So extremely thrilled about it.

Matt Howlett

analyst
#77

Yeah, so you're close to something, right? Is the figure 18, at which point you're able to give them a call and make them convert? Is that roughly the threshold?

Jay Jackson

executive
#78

Correct. Under the warrant agreement, the mechanics are that once the common stock hits 18 for a span of 20 or 30 days, we then have the ability to call those — we can call every warrant to be exercised at $11.50, which would in effect generate, you know, roughly $190 million-$200 million in cash for our balance sheet should that take place; we'll see, right? My sense is that's somewhat further down the road. Should it occur, you know, fantastic, we would be delighted to see those warrant holders become stockholders. But should it not, that's fine as well; yet as the stock keeps, you know, climbing on the basis of how the company performs, it's a real possibility that this could come to pass. I would be thrilled to have every one of those warrant holders switch over to common stockholders. And beyond that, when you consider what that $200 million would do, the effect it would have on our balance sheet, it would be considerable.

Matt Howlett

analyst
#79

Yeah, I mean, when it comes to the acquisitions, you simply have far more capital available to expand, and it comes at a low cost. So really—

Jay Jackson

executive
#80

Yeah

Matt Howlett

analyst
#81

... I have to give you credit for how you've handled capital, honestly.

Jay Jackson

executive
#82

Thanks. I appreciate it.

Matt Howlett

analyst
#83

Thank you very much.

Jay Jackson

executive
#84

Right, so if you consider that capital together with the EBITDA it generates, I believe that would have a dramatic effect — or a significant effect — on EBITDA for the next 12 months, correct? So, well, we'll see. Clearly, we're going to watch it very carefully, but it's certainly one of the approaches, together with debt and together with, you know, equity, that we would examine seriously in 2024.

Matt Howlett

analyst
#85

Yeah, that definitely places you in a positive feedback loop. I genuinely appreciate that, everyone.

Jay Jackson

executive
#86

Thank you, Matt.

Jay Jackson

executive
#87

Alright. Once more, thanks to all of you for being part of our earnings call and conference call for Q4 2023. Our excitement regarding what 2024 may bring could hardly be greater, and we wish to convey appreciation to all of our shareholders, to our research analysts, and to everyone who took part in today's call. We hope to collaborate with you further going forward. And as is our habit, should additional questions come up following this call, or if you would like to arrange some time with Bill and myself, please don't hesitate to get in touch. Enjoy the rest of your afternoon. Thanks.

Operator

operator
#88

Everyone, that brings today's teleconference to a close. We appreciate your participation. At this point you're welcome to disconnect your lines, and enjoy the rest of your day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.